Evidence map›Paper›PMID 33620435›Full record

ArticleEuropean heart journal. Acute cardiovascular care2021

The addition of echocardiographic parameters to PESI risk score improves mortality prediction in patients with acute pulmonary embolism: PESI-Echo score.

Lucrecia M Burgos, Cristhian E Scatularo, Ignacio M Cigalini, Juan C Jauregui, Maico I Bernal, José M Bonorino, Jorge Thierer, Ezequiel J Zaidel, Argentine Council of Cardiology Residents, Argentina

Open access · greenAbstract read
In one paragraph

Article in European heart journal. Acute cardiovascular care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Predictive Value of Wells, Geneva, Bova, and PESI Scores in Elderly Pulmonary Embolism Patients.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Derivation and Validation of a Prognostic Model for Mortality in Chinese Patients with Acute Pulmonary Embolism.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
  13. Prognostic Value of Inflammatory Biomarkers for Mortality in Intensive Care Patients with Acute Pulmonary Embolism: A Retrospective Observational Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Observational
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Lucrecia M BurgosArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.ORCID 0000-0002-3999-1265
Cristhian E ScatularoArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
Ignacio M CigaliniArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
Juan C JaureguiArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
Maico I BernalArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
José M BonorinoArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
Jorge ThiererArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
Ezequiel J ZaidelArgentine Council of Cardiology Residents, Azcuénaga 980, Buenos Aires 1115, Argentina.
Argentine Council of Cardiology Residents, Argentina

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPulmonary embolism severity index (PESI) has been developed to help physicians make decisions about the treatment of patients with pulmonary embolism (PE). The combination of echocardiographic parameters could potentially improve PESI's mortality prediction. To assess the additional prognostic value of tricuspid annular plane systolic excursion (TAPSE) and pulmonary artery systolic pressure (PASP) when combined with the PESI score in patients with PE to predict short-term mortality. METHODS AND

resultsA multicentric prospective study database of patients admitted with PE in 75 academic centres in Argentina between 2016 and 2017 was analysed. Patients with an echocardiogram at admission with simultaneous measurement of TAPSE and PASP were included. PESI risk score was calculated blindly and prospectively, and in-hospital all-cause mortality was assessed. Of 684 patients, 91% had an echocardiogram, PASP and TAPSE could be estimated simultaneously in 355 (57%). All-cause in-hospital mortality was 11%. The receiver operating characteristic analysis showed an area under the curve (AUC) [95% confidence interval (CI)] of 0.76 (0.72-0.81), 0.74 (0.69-0.79), and 0.71 (0.62-0.79), for the PESI score, PASP, and TAPSE parameters, respectively. When PESI score was combined with the echocardiogram parameters (PESI + PASP-TAPSE = PESI-Echo), an AUC of 0.82 (0.77-0.86) was achieved (P = 0.007). A PESI-Echo score ≥128 was the optimal cut-off point for predicting hospital mortality: sensitivity 82% (95% CI 67-90%), specificity 69% (95% CI 64-74%). The global net reclassification improvement was 9.9%.

conclusionsPESI-Echo score is a novel tool for assessing mortality risk in patients with acute PE. The addition of echocardiographic parameters to a validated clinical score improved the prediction of hospital mortality.

Indexed as

Pulmonary EmbolismAcute DiseaseEchocardiographyHumansPrognosisProspective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexArgentinaEchocardiographyMortalityPulmonary embolism

Identifiers

PMID33620435
PMCPMC8241311
OpenAlexW3124414278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.